Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 28551 - 28575 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cytarabine	Approved Investigational	MYLIP	29116	downregulated	Cytarabine results in decreased expression of MYLIP mRNA	6p22.3	A21886
Cytarabine	Approved Investigational	MYOF	26509	downregulated	Cytarabine results in decreased expression of MYOF mRNA	10q23.33	A21886
Cytarabine	Approved Investigational	NAV2	89797	downregulated	Cytarabine results in decreased expression of NAV2 mRNA	11p15.1	A21886
Cytarabine	Approved Investigational	NCALD	83988	upregulated	Cytarabine results in increased expression of NCALD mRNA	8q22.3	A21886
Cytarabine	Approved Investigational	NDC80	10403	upregulated	Cytarabine results in increased expression of NDC80 mRNA	18p11.32	A20985
Cytarabine	Approved Investigational	NDRG1	10397	downregulated	Cytarabine results in decreased expression of NDRG1 mRNA	8q24.22	A21886
Cytarabine	Approved Investigational	NDRG2	57447	downregulated	Cytarabine results in decreased expression of NDRG2 mRNA	14q11.2	A21886
Cytarabine	Approved Investigational	NELL2	4753	upregulated	Cytarabine results in increased expression of NELL2 mRNA	12q12	A21886
Cytarabine	Approved Investigational	NES	10763	upregulated	Cytarabine results in increased expression of NES mRNA	1q23.1	A21886
Cytarabine	Approved Investigational	NFIB	4781	upregulated	Cytarabine results in increased expression of NFIB mRNA	9p23-p22.3	A21886
Cytarabine	Approved Investigational	NMU	10874	upregulated	Cytarabine results in increased expression of NMU mRNA	4q12	A21886
Cytarabine	Approved Investigational	NOVA1	4857	upregulated	Cytarabine results in increased expression of NOVA1 mRNA	14q12	A21886
Cytarabine	Approved Investigational	NOX4	50507	downregulated	Cytarabine results in decreased expression of NOX4 mRNA	11q14.3	A21886
Cytarabine	Approved Investigational	NPPB	4879	upregulated	Cytarabine results in increased expression of NPPB mRNA	1p36.22	A21886
Cytarabine	Approved Investigational	NPY	4852	downregulated	Cytarabine results in decreased expression of NPY mRNA	7p15.3	A21886
Cytarabine	Approved Investigational	NRIP3	56675	downregulated	Cytarabine results in decreased expression of NRIP3 mRNA	11p15.4	A21886
Cytarabine	Approved Investigational	NTM	50863	downregulated	Cytarabine results in decreased expression of NTM mRNA	11q25	A21886
Cytarabine	Approved Investigational	NTNG1	22854	upregulated	Cytarabine results in increased expression of NTNG1 mRNA	1p13.3	A21886
Cytarabine	Approved Investigational	ODAM	54959	downregulated	Cytarabine results in decreased expression of ODAM mRNA	4q13.3	A21886
Cytarabine	Approved Investigational	OLFML3	56944	downregulated	Cytarabine results in decreased expression of OLFML3 mRNA	1p13.2	A21886
Cytarabine	Approved Investigational	OLR1	4973	downregulated	Cytarabine results in decreased expression of OLR1 mRNA	12p13.2	A21886
Cytarabine	Approved Investigational	OSBPL10	114884	downregulated	Cytarabine results in decreased expression of OSBPL10 mRNA	3p23	A21886
Cytarabine	Approved Investigational	OSR1	130497	downregulated	Cytarabine results in decreased expression of OSR1 mRNA	2p24.1	A21886
Cytarabine	Approved Investigational	P4HA2	8974	downregulated	Cytarabine results in decreased expression of P4HA2 mRNA	5q31.1	A21886
Cytarabine	Approved Investigational	PAGE4	9506	downregulated	Cytarabine results in decreased expression of PAGE4 mRNA	Xp11.23	A21886

Displaying entries 28551 - 28575 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability